Abstract
Lenvatinib demonstrated a treatment effect on overall survival by the statistical confirmation of non-inferiority to sorafenib for the first-line treatment of uHCC. The objective of this study was to evaluate the cost-effectiveness of lenvatinib compared with sorafenib for patients with uHCC in Japan. A partitioned-survival model was developed to estimate the cost-effectiveness of lenvatinib versus sorafenib when treating uHCC patients over a lifetime horizon and considering total public healthcare expenditure. Efficacy and safety data were extracted from the REFLECT trial. Utility values were derived from the European Quality-of-Life 5-Dimension Questionnaire, conducted with patients enrolled in the REFLECT trial. Direct medical costs, such as primary drug therapy, outpatient visits, diagnostic tests, hospitalization, post-progression therapy, and adverse-event treatments, were included. Cost parameters unavailable in the clinical trial or publications were obtained based on the consolidated clinical standards from a Delphi panel of four Japanese medical experts. For lenvatinib versus sorafenib, the incremental cost was - 406,307 Japanese Yen (JPY), and the incremental life years and quality-adjusted life years (QALYs) were 0....Continue Reading
References
Jul 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K IkedaM Kawanishi
Aug 1, 1996·Journal of Gastroenterology·T ChibaT Osuga
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 20, 2008·The Lancet Oncology·Ann-Lii ChengZhongzhen Guan
Apr 22, 2009·Health Economics·Takeru ShiroiwaKiichiro Tsutani
Mar 17, 2010·Current Medical Research and Opinion·Paul SwinburnMaureen P Neary
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Andrew H BriggsUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Mar 7, 2013·Journal of Gastroenterology·Mi Na KimKwang-Hyub Han
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J JohnsonAnn-Lii Cheng
Oct 2, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann-Lii ChengEric Raymond
Jun 19, 2014·Current Oncology·N MollaM Hassanain
Dec 10, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Calin CainapSaied El-Nowiem
Dec 31, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuYoon-Koo Kang
Feb 12, 2015·The New England Journal of Medicine·Martin SchlumbergerSteven I Sherman
Oct 7, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Phil McEwanHiromitsu Kumada
Oct 21, 2015·The Lancet Oncology·Robert J MotzerJames Larkin
Mar 5, 2016·Journal of Gastroenterology·Shuichi KanekoKiwamu Okita
Apr 24, 2016·Journal of Gastroenterology·Masatoshi KudoNorihiro Kokudo
May 22, 2016·BMC Medical Research Methodology·Breda H EubankDavid M Sheps
Oct 28, 2016·Journal of Hepatocellular Carcinoma·Julius BaloghHoward P Monsour
Dec 10, 2016·Lancet·Jordi BruixUNKNOWN RESORCE Investigators
Jul 9, 2017·Health Policy·Takeru ShiroiwaTomoyuki Takura
Dec 19, 2017·Journal of Cancer Research and Clinical Oncology·Franco TrevisaniGiovan Giuseppe Di Costanzo
Jan 10, 2018·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Terumi KaishimaJunko Tanaka
Feb 13, 2018·Lancet·Masatoshi KudoAnn-Lii Cheng
Apr 7, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jorge A MarreroJulie K Heimbach
Citations
Nov 22, 2019·The Oncologist·John J KimWilliam W L Wong
May 19, 2020·Journal of Comparative Effectiveness Research·Hongfu CaiMaobai Liu
Jun 27, 2019·Cancers·Kehua Zhou, Christos Fountzilas
Sep 24, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Weiting LiaoQiu Li
Nov 21, 2019·Alimentary Pharmacology & Therapeutics·Saroja BangaruAmit G Singal
Apr 23, 2020·BMC Gastroenterology·Maximilian SiegHabibollah Arefian
Apr 21, 2020·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takeshi TerashimaShuichi Kaneko
Apr 18, 2019·Drugs·Zaina T Al-SalamaLesley J Scott
Aug 3, 2019·Cancers·Masatoshi KudoNaoshi Nishida
Aug 13, 2020·Signal Transduction and Targeted Therapy·Ao HuangJian Zhou
Jul 14, 2020·Oncotarget·Tetsu TomonariTetsuji Takayama
Aug 11, 2020·Hepatic Oncology·Abdalla AlyFernando Benavente
Nov 4, 2020·Clinical Drug Investigation·Masnoon SaiyedMartin Downes
Jul 1, 2020·Current Gene Therapy·Chen-Hao ZhangQiang Gao
Feb 7, 2020·Journal of Clinical and Experimental Hepatology·Ashish KumarUNKNOWN INASL Task-Force on Hepatocellular Carcinoma
Feb 2, 2021·Internal Medicine·Atsuyuki IkedaHiroyuki Kokuryu
Feb 9, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Feng WenQiu Li
Nov 17, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D GordanMichal G Rose
Feb 2, 2021·Value in Health Regional Issues·Shunya IkedaShuichi Kaneko
Feb 28, 2021·Colloids and Surfaces. B, Biointerfaces·Shuangshuang ZhangHui Li
Mar 13, 2020·The Oncologist·John J KimWilliam W L Wong
Jul 13, 2020·Clinical Therapeutics·Munenobu Kashiwa, Ryo Matsushita
Mar 27, 2021·Frontiers in Oncology·Meiyue LiXiuhua Weng
Apr 8, 2021·JAMA Network Open·Xin ZhangWenjun Wang
Apr 23, 2021·Journal of Hepatocellular Carcinoma·Angelo DipasqualeArmando Santoro
Jul 22, 2021·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takeshi TerashimaShuichi Kaneko
Aug 25, 2021·PharmacoEconomics Open·Sydney C YuenT Joseph Mattingly
Nov 6, 2021·Abdominal Radiology·Zhiqing MoLiling Long
Oct 22, 2020·Liver Cancer·Christopher SherrowChristos Fountzilas
Nov 10, 2021·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Yuji TohdaIchiro Arakawa